Literature DB >> 27490592

Pulmonary Hypertension.

Peter Oishi1, Jeffrey R Fineman.   

Abstract

OBJECTIVES: To review the clinical classification, diagnosis, and pathophysiology of pulmonary hypertension in children, emphasizing the role of right ventricular function, ventricular interaction, and congenital heart disease in the evolution and progression of disease, as well as management strategies and therapeutic options. DATA SOURCE: MEDLINE, PubMed.
CONCLUSIONS: Critically ill children with pulmonary hypertension associated with congenital heart disease are a high-risk population. Congenital cardiac defects resulting in either increased pulmonary blood flow or impaired pulmonary venous drainage predispose patients to developing structural and functional aberrations of the pulmonary vasculature. Mortality from pulmonary hypertension is most directly related to right ventricular failure.

Entities:  

Mesh:

Year:  2016        PMID: 27490592      PMCID: PMC4975433          DOI: 10.1097/PCC.0000000000000754

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  52 in total

1.  Significant left ventricular contribution to right ventricular systolic function.

Authors:  R J Damiano; P La Follette; J L Cox; J E Lowe; W P Santamore
Journal:  Am J Physiol       Date:  1991-11

2.  Tricuspid annular displacement predicts survival in pulmonary hypertension.

Authors:  Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2006-08-03       Impact factor: 21.405

3.  Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes.

Authors:  A M Rudolph; S Yuan
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

4.  Dopamine effects on pulmonary artery pressure in hypotensive preterm infants with patent ductus arteriosus.

Authors:  Jean-Michel Liet; Cécile Boscher; Christèle Gras-Leguen; Véronique Gournay; Thierry Debillon; Jean-Christophe Rozé
Journal:  J Pediatr       Date:  2002-03       Impact factor: 4.406

5.  Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management.

Authors:  K Bando; M W Turrentine; T G Sharp; Y Sekine; T X Aufiero; K Sun; E Sekine; J W Brown
Journal:  J Thorac Cardiovasc Surg       Date:  1996-12       Impact factor: 5.209

6.  New predictors of outcome in idiopathic pulmonary arterial hypertension.

Authors:  Steven M Kawut; Evelyn M Horn; Ketevan K Berekashvili; Robert P Garofano; Rochelle L Goldsmith; Allison C Widlitz; Erika B Rosenzweig; Diane Kerstein; Robyn J Barst
Journal:  Am J Cardiol       Date:  2005-01-15       Impact factor: 2.778

7.  A blind, randomized comparison of the circulatory effects of dopamine and epinephrine infusions in the newborn piglet during normoxia and hypoxia.

Authors:  K J Barrington; N N Finer; W K Chan
Journal:  Crit Care Med       Date:  1995-04       Impact factor: 7.598

8.  The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations.

Authors:  G J Vlahakes; K Turley; J I Hoffman
Journal:  Circulation       Date:  1981-01       Impact factor: 29.690

9.  Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.

Authors:  D Dunbar Ivy; Aimee K Doran; Kelly J Smith; George B Mallory; Maurice Beghetti; Robyn J Barst; Daniela Brady; Yuk Law; Donna Parker; Lori Claussen; Steven H Abman
Journal:  J Am Coll Cardiol       Date:  2008-01-15       Impact factor: 24.094

10.  Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics.

Authors:  D S Celermajer; S Cullen; J E Deanfield
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

View more
  6 in total

1.  Bioinformatic analysis of dysregulated circular RNAs in pediatric pulmonary hypertension linked congenital heart disease.

Authors:  Danyan Su; Yanyun Huang; Dongli Liu; Yuqin Huang; Bingbing Ye; Suyuan Qin; Cheng Chen; Yusheng Pang
Journal:  Transl Pediatr       Date:  2022-05

Review 2.  Pediatric Perioperative Pulmonary Arterial Hypertension: A Case-Based Primer.

Authors:  Shilpa Shah; Jacqueline R Szmuszkovicz
Journal:  Children (Basel)       Date:  2017-10-24

3.  Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy.

Authors:  Maria F Acosta; Priya Muralidharan; Carissa L Grijalva; Michael D Abrahamson; Don Hayes; Jeffrey R Fineman; Stephen M Black; Heidi M Mansour
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 5.158

4.  Hemodynamically Unloading the Distal Pulmonary Circulation in Pulmonary Hypertension: A Modeling Study.

Authors:  Rachelle Walter; Kendall Hunter; Kurt Stenmark; Vitaly O Kheyfets
Journal:  J Biomech Eng       Date:  2022-02-01       Impact factor: 2.097

5.  Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH.

Authors:  Maria F Acosta; Priya Muralidhran; Michael D Abrahamson; Carissa L Grijalva; Megan Carver; Haiyang Tang; Christina Klinger; Jeffrey R Fineman; Stephen M Black; Heidi M Mansour
Journal:  Pulm Pharmacol Ther       Date:  2021-02-05       Impact factor: 3.410

6.  Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers.

Authors:  Maria F Acosta; Michael D Abrahamson; David Encinas-Basurto; Jeffrey R Fineman; Stephen M Black; Heidi M Mansour
Journal:  AAPS J       Date:  2020-11-16       Impact factor: 3.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.